Can Ceftriaxone Cause Burning at the Venous Injection Site?
Yes, ceftriaxone can cause burning, pain, and discomfort at the venous injection site, though this is more commonly reported with intramuscular administration. 1
Local Injection Site Reactions
The FDA drug label for ceftriaxone explicitly documents local reactions as adverse events:
- Pain, induration, and tenderness occurred in 1% of patients overall 1
- Phlebitis was reported in <1% after IV administration 1
- Injection site pain occurred in 0.6% of patients 1
The label specifically notes that "the incidence of warmth, tightness or induration was 17% (3/17) after IM administration of 350 mg/mL and 5% (1/20) after IM administration of 250 mg/mL" 1, indicating concentration-dependent local reactions.
Clinical Context and Recognition
One guideline addressing catheter-related complications notes that "complaints of local pain or a burning sensation during injection" are common first signs of various catheter-related issues 2. While this reference discusses thrombotic complications, it acknowledges that burning sensations during injection are recognized clinical phenomena.
In a large safety analysis of 2,640 patients, local reactions occurred in 1.86% of cases overall 3. The frequency of local adverse effects was statistically higher when ceftriaxone was administered twice daily compared to once daily 3.
Practical Considerations
For Intravenous Administration:
- Administer slowly over appropriate infusion time (typically ≥30 minutes for IV infusion)
- The FDA label warns that vancomycin should be infused over ≥1 hour to reduce "red man" syndrome 4, and similar slow infusion principles apply to ceftriaxone
- Ensure proper dilution and avoid rapid IV push
- One Iranian pharmacovigilance study identified rapid intravenous injection as a specific risk factor for adverse events 5
For Intramuscular Administration:
- Using 1% lidocaine as a diluent significantly reduces injection pain compared to sterile water 6, 7
- The FDA label notes: "Some health-care providers believe that the discomfort of the injection may be reduced by using 1% lidocaine solution as a diluent" 1
- Studies confirm no difference in bioequivalence between lidocaine and water diluents, but significantly less pain with lidocaine 7
Important Safety Caveat
While local burning is generally a minor adverse effect, be vigilant for more serious reactions. The Iranian pharmacovigilance database reported ceftriaxone was responsible for the highest number of deaths in their system (49 cases), with 30% of adverse events categorized as serious 5. Rapid IV injection and previous allergic history to beta-lactams are significant risk factors 5.
If burning is accompanied by systemic symptoms (respiratory distress, hypotension, urticaria), immediately discontinue the infusion and treat for potential anaphylaxis 8.